Floatz logo

Therapeutic Asset Ratings

374 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Interferon Beta 1
Relapsing-Remitting Multiple Sclerosis
Novartis PharmaceuticalsP2CCC (53)
jsb462
Prostate Cancer
Novartis PharmaceuticalsP2CCC (53)
jsb462
Prostatic Cancer, Castration-Resistant
Novartis PharmaceuticalsP2CCC (53)
Osimertinib
Advanced Solid Tumors Which Are cMET-dependent
Novartis PharmaceuticalsP2CCC (53)
Rapcabtagene Autoleucel
Diffuse Scleroderma
Novartis PharmaceuticalsP2CCC (53)
Ribociclib
Continued Access to Study Treatment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Cancer, Advanced Solid Tumors, Advanced Solid Malignancies
Novartis PharmaceuticalsP2CCC (53)
Spartalizumab
Renal Cell Carcinoma
Novartis PharmaceuticalsP2CCC (53)
vhb937
Amyotrophic Lateral Sclerosis
Novartis PharmaceuticalsP2CCC (53)
VIPIVOTIDE TETRAXETAN
Prostatic Cancer, Castration-Resistant
Novartis PharmaceuticalsP2CCC (53)
Pembrolizumab
Nasopharyngeal Carcinoma
Novartis PharmaceuticalsP1/2CCC (53)
Spartalizumab
Non-Small Cell Lung Carcinoma
Novartis PharmaceuticalsP2CCC (52)
Zoladex
Melanoma
Novartis PharmaceuticalsP2CCC (52)
MIDAZOLAM
Acute Myeloid Leukemia
Novartis PharmaceuticalsP1/2CCC (52)
ltp001
Idiopathic Pulmonary Fibrosis
Novartis PharmaceuticalsP2CCC (51)
vhb937
Alzheimer Disease
Novartis PharmaceuticalsP2CCC (51)
IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 1.BETA.) (HUMAN CLONE ACZ885 HEAVY CHAIN V REGION)
Cognitive Disorder
Novartis PharmaceuticalsP2CCC (50)
Epirubicin
Nasopharyngeal Carcinoma
Novartis PharmaceuticalsP1/2CCC (50)
FULVESTRANT
Advanced HR+/HER2- Breast Cancer
Novartis PharmaceuticalsP1/2CCC (50)
Letrozole
Advanced HR+/HER2- Breast Cancer
Novartis PharmaceuticalsP1/2CCC (50)
egf816
Non-Small Cell Lung Carcinoma
Novartis PharmaceuticalsP2CCC (49)
Axicabtagene Ciloleucel
Acute Lymphoblastic Leukemia
Novartis PharmaceuticalsP2CCC (48)
Capmatinib
Advanced Solid Tumors Which Are cMET-dependent
Novartis PharmaceuticalsP2CCC (48)
gxv813
Schizophrenia
Novartis PharmaceuticalsP2CCC (48)
IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 1.BETA.) (HUMAN CLONE ACZ885 HEAVY CHAIN V REGION)
Alzheimer Disease
Novartis PharmaceuticalsP2CCC (48)
Ociperlimab
Triple-Negative Breast Carcinoma
Novartis PharmaceuticalsP2CCC (48)
Showing 126 to 150 of 374 assets
PreviousPage 6 of 15Next